Assorted News from the Last Week: Congressman Michael McCaul with Childhood Cancer Caucus co-chairs Ami Bera, M.D. (D-Calif.) and Mike Kelly (R-Penn.)introduced the Accelerating Innovation

Assorted News from the Last Week: Researchers advance fertility options for childhood cancer survivors. Pediatric cancer survival has improved substantially in recent decades; however, these

Assorted News from the Last Week: CAC2 Member Regina Karchner (Childhood Brain Cancer Foundation) focuses the light on survivorship as we end Survivorship Month with

Assorted News from the Last Week: Replacing two high-dose chemotherapy courses with blinatumomab (Blincyto) significantly improved event-free survival (EFS) in pediatric patients with newly diagnosed

Assorted News from the Last Week: CAC2 Supporting Organization Blood Cancer United is buying remaining supplies of Luvelta and will manage a compassionate-use program to

Assorted News from the Last Week: AACR issued a Special Edition Advocacy Alert for National Cancer Survivor Month, with several pediatric-focused articles. Children’s brain tumors

Assorted News from the Last Week: The FDA has granted rare pediatric disease designation and orphan drug designation to FL118 for the treatment of patients

Assorted News from the Last Week: Black pediatric AML patients had more than twice the risk of acute kidney injury during treatment as their White

Assorted News from the Last Week: Childhood cancer from a parent’s point of view. U.S. Rep. Debbie Wasserman Schultz (FL-25), Rep. Brian Fitzpatrick(PA-1), Rep. Mark

Assorted News from the Last Week: CAC2 Supporting Organizations Day One and Servier completed enrollment in pivotal Phase 3 FIREFLY-2 Trial of Tovorafenib as a